Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEarly plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation
World Journal of Gastroenterology, 07/20/09
Kamar N et al. – The authors conclude that plasmapheresis should be started as soon as AHR is diagnosed, and be associated with a B–cell depleting agent. Rituximab may be considered as a first–line therapy.
Related Articles
Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients
Clinical Transplantation, 11/20/09
Relevance Score: 72%
Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 72%
Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation
Clinical Transplantation, 11/20/09
Relevance Score: 70%
Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay
Clinical Transplantation, 11/18/09
Relevance Score: 70%
Two-stage liver transplantation: an effective procedure in urgent conditions
Clinical Transplantation, 10/23/09
Relevance Score: 70%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment
Annals of Surgical Oncology, 12/15/09
Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09
Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer
The Journal of Thoracic and Cardiovascular Surgery, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor